全体要約
2023年には、サービス分野が最も高い成長率を示すと予測され、ソフトウェアが市場の最大シェアを占めています。応用分野では、医療現場での人為的エラーの軽減や治療効果向上に貢献することから、体内診断（in vivo）セグメントが最大のシェアを占めると見込まれています。地域別では、2023年に北米が最大市場シェアを持つ一方、アジア太平洋地域が最高のCAGRを示すと予測されています。主な企業には、マイクロソフト、NVIDIA、インテル、シーメンスヘルスケア、GEヘルスケアなどがあります。
関連する質問
37億USD（2028年）
23.2%（2023年から2028年）
Microsoft, NVIDIA Corporation, Merative, Intel Corporation, Google, Siemens Healthineers, GE HealthCare, Digital Diagnostics Inc., Advanced Micro Devices, Inc., InformAI, HeartFlow, Inc., Enlitic, Inc., isometric, Aidence, Butterfly Network, Inc., Nano-X Imaging LTD., Viz.ai, Inc, Quibim, Qure.ai, Therapixel, Aidoc, Koninklijke Philips N.V., Lunit, Inc., EchoNous, Inc., Brainomix
ビッグデータの流入, 政府のAI技術推進の取り組みの増加, 放射線科医の負荷軽減のためのAIソリューションの採用 증가
概要
しかし、訓練されたAI人材の不足や不安定な規制は、市場成長を制約する要因と予想されています。
「サービスセグメントは2023年から2028年にかけて最も高い成長率を期待されています。」
コンポーネント別に、医療診断におけるAI市場はソフトウェア、ハードウェア、サービスに分かれています。ソフトウェアセグメントは2022年にこの市場の最大のシェアを占めていましたが、サービスセグメントは2023年から2028年にかけてより高いCAGRで成長すると予測されています。ソフトウェアソリューションは、医療提供者がスタッフが不足しているという課題や、増加する画像スキャンのボリュームに直面しながらも競争優位性を得ることを可能にします。
「インビボ診断セグメントは、2023年の世界の医療診断におけるAI市場の最大のシェアを占めると推定されています。」
用途別に、医療診断におけるAI市場は、in vivo（体内）診断とin vitro（体外）診断に分かれています。2023年には、in vivo診断セグメントがこの市場で最大のシェアを占めると予測されています。実務者によるAIソリューションの利用が増加している要因として、これらのソリューションが人為的エラーの減少に常に寄与し、治療の効果を高めることが挙げられます。しかし、in vitro診断セグメントは予測期間中に最も高い成長を記録することが予測されています。分析とデータ解釈の時間を短縮するために、in vitro診断アプリケーションへのAIソリューションの採用が増加しています。
「病院セグメントは、2023年における世界の医療診断におけるAI市場の最大のシェアを占めると予測されています。」
エンドユーザー別に、医療診断におけるAI市場は、病院、診断画像センター、診断検査室、その他のエンドユーザーに分かれています。2023年には、病院セグメントがこの市場の最大の市場シェアを占めると予測されています。患者ケアの質を向上させるために病院での低侵襲手技の採用が増加していることや、ワークフローを改善するための高度な画像モダリティの適用が進んでいることなどの要因があります。
「北米が2023年の医療診断におけるAI市場を支配します。」
地域別に見ると、医療診断におけるAI市場は、北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東およびアフリカの5つの主要地域セグメントに分かれています。2023年には、北米がこの市場の最大の市場シェアを占めると見込まれています。しかし、アジア太平洋市場は2023年から2028年の間に最も高いCAGRを記録すると予測されています。癌の発生率の増加や、有利な政府の取り組みの実施などの要因があります。
供給側の一次インタビューの内訳、企業タイプ、職名、および地域別：
• 会社タイプ別：ティア1（40％）、ティア2（30％）、ティア3（30％）
• 地位別：C級（27%）、ディレクター級（18%）、その他（55%）
地域別: 北米（40%）、欧州（20%）、アジア太平洋（30%）、その他の地域（10%）
この市場の主要なプレーヤーは、マイクロソフト（アメリカ）、NVIDIAコーポレーション（アメリカ）、Merative（アメリカ）、インテルコーポレーション（アメリカ）、グーグル（アメリカ）、シーメンスヘルスケア（ドイツ）、GEヘルスケア（アメリカ）、デジタル診断社（アメリカ）、アドバンストマイクロデバイセズ社（アメリカ）、InformAI（アメリカ）、ハートフロー社（アメリカ）、エンリティック社（アメリカ）、アイソメトリック（ベルギー）、アイデンス（オランダ）、バタフライネットワーク社（アメリカ）、ナノ-Xイメージング社（イスラエル）、Viz.ai, Inc（アメリカ）、Quibim（スペイン）、Qure.ai（インド）、Therapixel（フランス）、Aidoc（アメリカ）、ロイヤルフィリップスN.V.（オランダ）、ルニット社（韓国）、エコナス社（アメリカ）、およびブラノミックス社（イギリス）です。
調査範囲
レポートは、コンポーネント、アプリケーション、エンドユーザー、および地域に基づいて医療診断におけるAI市場を調査しています。
この報告書は、市場の成長に影響を与える要因（推進要因、制約、機会、課題など）を分析しています。
この報告書は、ステークホルダーにとっての市場の機会と課題を評価し、市場リーダーの競争環境の詳細を提供します。
この報告書は、医療診断におけるAI市場全体への成長トレンド、展望、および貢献に関するマイクロマーケットを調査しています。
レポートは、5つの主要地域に関する市場セグメントの収益を予測します。
報告書購入の主な利点：
このレポートは、この市場のリーダーや新規参入者に対して、全体市場およびサブセグメントの収益数値の最も近い近似値に関する情報を提供します。このレポートは、利害関係者が競争環境を理解し、ビジネスをより良く位置づけ、適切な市場進出戦略を計画するための洞察を得るのに役立ちます。また、このレポートは、利害関係者が医療診断におけるAIの動向を理解し、市場の主要なドライバー、制約、課題、機会に関する情報を提供します。
このレポートは以下のポイントに関する洞察を提供します。
• 主要原動力の分析（ビッグデータの流入、産業間パートナーシップとコラボレーションの増加、放射線科医の負担を軽減するためのAIソリューションの導入増加、AIベースの技術を推進するための政府の取り組みの増加、AIベースのスタートアップに対する資金の availability）、制約（不十分なAI労働力および医療ソフトウェアのあいまいな規制ガイドライン）、機会（未開拓の新興市場、人間を意識したAIシステムの開発に対する焦点の増加）、課題（AIベースの技術の導入に対するためらい、予算の制約、非構造化医療データ、データプライバシーの懸念、限られた相互運用性）
・市場浸透：グローバル医療診断におけるAI市場の主要プレーヤーが提供する製品ポートフォリオに関する包括的な情報です。レポートでは、この市場をコンポーネント、アプリケーション、エンドユーザー別に分析しています。
サービスの向上/革新：グローバルAI医療診断市場における今後のトレンドに関する詳細な洞察
• 市場開発：コンポーネント、アプリケーション、エンドユーザー別の有望な新興市場に関する包括的な情報。
• 市場の多様化：医療診断におけるAI市場の新しいサービスやサービスの強化、成長する地域、最近の動向、および投資に関する包括的な情報
• 競争評価：グローバルな医療診断におけるAI市場における主要プレーヤーの市場シェア、成長戦略、製品提供、企業評価四象限、及び能力の詳細な評価です。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 45
1.1 調査の目的 45
1.2 市場の定義 45
1.2.1 包含・除外事項 45
1.3 市場範囲 46
1.3.1 対象市場 46
1.3.2 対象年 46
1.3.3 通貨 47
1.4 ステークホルダー 47
1.5 変化のサマリー 47
1.6 リセッション時のインパクト 48
2 調査手法 49
2.1 リサーチデータ 49
2.1.1 二次データ 50
- 2.1.1.1 二次情報の主要データ 50
2.1.2 一次データ 51
- 2.1.2.1 一次情報の主要データ 53
- 2.1.2.2 業界についての主な考察 53
2.2 市場規模予測 54
2.3 市場データ予測・トライアンギュレーション 59
2.4 前提 60
2.5 制約 60
2.5.1 範囲上の制約 60
2.5.2 手法上の制約 60
2.6 リスク評価 61
2.7 医療診断におけるAI市場：景気後退の影響分析 61
3 エグゼクティブサマリー 62
4 更なる考察 65
4.1 医療診断におけるAI市場の概要 65
4.2 北米の医療診断におけるAI市場：用途別、国別（2022年） 66
4.3 医療診断におけるAI市場：地域別の成長機会 66
4.4 医療診断におけるAI市場：地域ミックス 67
4.5 医療診断市場におけるAI：先進国市場と新興国市場の比較 67
5 市場概要 68
5.1 イントロダクション 68
5.1.1 促進要因 69
5.1.2 抑制要因 72
- 5.1.2.1 不十分なAI労働力と曖昧な医療ソフトウェアの規制ガイドライン 72
5.1.3 市場機会 72
- 5.1.3.1 未開拓の新興国市場 72
- 5.1.3.2 人間を意識したAIシステムの開発への注目度が高まる 73
5.1.4 課題 73
- 5.1.4.1 AIベースのテクノロジーの導入に消極的 73
- 5.1.4.2 予算上の制約 74
- 5.1.4.3 非構造化医療データ 74
- 5.1.4.4 データプライバシー懸念 74
- 5.1.4.5 限られた相互運用性 75
5.2 お客様のビジネスに影響を与えるトレンド/混乱 75
5.3 バリューチェーン分析 75
5.3.1 上流 76
5.3.2 ミドル・ストリーム 77
5.3.3 下流 77
5.4 エコシステムマッピング 77
5.4.1 エコシステムにおける役割 78
5.5 ケーススタディ 79
5.6 技術分析 81
5.6.1 機械学習 81
5.6.2 自然言語処理 81
5.6.3 コンピュータービジョン 81
5.7 ポーターのファイブフォース分析 82
5.7.1 新規参入の脅威 83
5.7.2 代替品の脅威 83
5.7.3 サプライヤーの交渉力 83
5.7.4 買い手の交渉力 83
5.7.5 競合・競争状況の激しさ 84
5.8 業界トレンド 84
5.8.1 ヘルスケア向け人工知能（AI） 84
5.9 取引分析・貿易分析 85
5.10 課税・規制分析 86
5.10.1 医療診断ハードウェアにおけるAIの関税 86
5.10.2 規制当局、政府機関、その他組織 87
5.10.3 北米 90
5.10.4 ヨーロッパ 92
5.10.5 アジア太平洋 93
- 5.10.5.1 中華人民共和国サイバーセキュリティ法 93
5.10.6 その他地域 93
- 5.10.6.1 個人情報保護法 93
5.11 価格分析 94
5.11.1 平均販売価格トレンド 95
5.12 特許分析 95
5.12.1 医療診断における人工知能の特許公開動向 95
5.12.2 考察：管轄とトップ参加者の分析 95
5.13 主な会議・イベント（2023年～2024年） 98
5.14 主なステークホルダーと購入基準 99
5.14.1 購買プロセスにおける主要ステークホルダー 99
5.14.2 購買基準 100
5.15 満たされないニーズ医療診断市場におけるAI 101
5.16 エンドユーザーの期待 102
5.17 払い戻しシナリオ 103
5.17.1 放射線科におけるAIソフトウェアの診療報酬 105
6 医療診断における人工知能の市場、コンポーネント別 106
6.1 イントロダクション 107
6.2 ソフトウェア 107
6.3 サービス 109
6.4 ハードウェア 111
6.4.1 市場成長を支える最適使用のための頻繁なアップグレード 111
6.4.2 プロセッサー 113
- 6.4.2.1 エムピーユー 115
- 6.4.2.1.1 MPUがプロセッサ市場で最大シェアを占める 115
- 6.4.2.2 GPU 116
- 6.4.2.3 FPGA 118
- 6.4.2.3.1 需要を牽引する幅広い利用可能性 118
- 6.4.2.4 ASIC 119
- 6.4.2.4.1 エンドユーザーの需要をサポートする迅速なオペレーション 119
- 6.4.2.1 エムピーユー 115
6.4.3 メモリ半導体 121
- 6.4.3.1 AIアプリケーション向け広帯域メモリが市場を牽引 121
6.4.4 ネットワーク 122
- 6.4.4.1 アダプター 124
- 6.4.4.1.1 アダプタがネットワーク市場で最大シェアを占める 124
- 6.4.4.2 スイッチ 126
- 6.4.4.3 インターコネクト 127
- 6.4.4.3.1 効率的なデータ通信が市場を牽引 127
- 6.4.4.1 アダプター 124
7 医療診断における人工知能市場：用途別 129
7.1 イントロダクション 130
7.2 in Vivo Diagnostics 131
7.2.1 生体内診断薬市場：専門分野別 131
- 7.2.1.1 放射線学 133
- 7.2.1.1.1 放射線科医の負担を軽減するAIベースの診断ツール 133
- 7.2.1.2 循環器内科 134
- 7.2.1.2.1 CVDに関連する複雑性の高まりが市場を牽引 134
- 7.2.1.3 神経学 136
- 7.2.1.3.1 重篤な脳障害の有病率の増加が市場を牽引 136
- 7.2.1.4 産科・婦人科 138
- 7.2.1.5 眼科 139
- 7.2.1.6 その他の専門分野 141
- 7.2.1.1 放射線学 133
7.2.2 生体内診断市場：モダリティ別 142
- 7.2.2.1 CT 144
- 7.2.2.2 X線 146
- 7.2.2.3 MRI 147
- 7.2.2.3.1 技術進歩の高まりがMRIにおけるAIの採用を促進 147
- 7.2.2.4 超音波 149
- 7.2.2.4.1 卵巣がん罹患率の増加が需要を押し上げる 149
- 7.2.2.5 その他のモダリティ 150
7.3 IVD 152
8 医療診断における人工知能の市場：エンドユーザー別 154
8.1 イントロダクション 155
8.2 病院 156
8.2.1 先進的AI画像診断ソリューションの導入が市場を牽引 156
8.3 画像診断センター 157
8.3.1 民間画像診断センターの増加が市場を牽引 157
8.4 検査室 159
8.4.1 検体検査量の増加が市場を牽引 159
8.5 その他のエンドユーザー 160
9 医療診断における人工知能の市場、地域別推移 162
9.1 イントロダクション 163
9.2 北米 164
9.2.1 北米：リセッション時のインパクト 164
9.2.2 米国 172
- 9.2.2.1 画像処理件数の増加が市場を牽引 172
9.2.3 カナダ 178
- 9.2.3.1 研究助成金と放射線医学の学術向上が市場を牽引 178
9.3 ヨーロッパ 184
9.3.1 ヨーロッパ：リセッション時のインパクト 184
9.3.2 ドイツ 191
9.3.3 フランス 197
9.3.4 英国 203
- 9.3.4.1 X線撮影手技の増加が市場を牽引 203
9.3.5 イタリア 209
9.3.6 スペイン 215
- 9.3.6.1 スペインで高まるAIへの認識が市場成長を後押し 215
9.3.7 その他ヨーロッパ 221
9.4 アジア太平洋 227
9.4.1 アジア太平洋：リセッション時のインパクト 227
9.4.2 中国 235
- 9.4.2.1 臨床上の意思決定におけるAI利用の増加が市場を牽引 235
9.4.3 日本 241
- 9.4.3.1 高度なAIソリューションの導入を促進する強力な医療インフラ 241
9.4.4 インド 246
- 9.4.4.1 研究開発投資に対する政府の積極的な取り組みが市場を牽引 246
9.4.5 その他アジア太平洋 253
9.5 ラテンアメリカ 259
9.6 中東・アフリカ 265
9.6.1 医療費の増加がAIの成長を促す 265
9.6.2 中東・アフリカ：リセッション時のインパクト 265
10 競合情勢 271
10.1 概要 271
10.2 主要企業の成功戦略 271
10.3 収益分析 272
10.4 市場シェア分析 273
10.5 企業評価マトリックス 275
10.5.1 STARS 275
10.5.2 EMERGING LEADERS 275
10.5.3 PERVASIVE PLAYERS 275
10.5.4 PARTICIPANTS 276
10.5.5 企業フットプリント分析 276
10.6 スタートアップ/中小企業評価マトリックス 278
10.6.1 PROGRESSIVE COMPANIES 278
10.6.2 DYNAMIC COMPANIES 278
10.6.3 RESPONSIVE COMPANIES 278
10.6.4 STARTING BLOCKS 278
10.6.5 競合ベンチマーキング 279
10.7 競合シナリオ 281
10.7.1 製品ローンチ・改良 281
10.7.2 ディール 282
10.7.3 その他の展開 283
11 企業プロファイル 284
11.1 主要企業 284
11.1.1 MICROSOFT 284
11.1.2 NVIDIA CORPORATION 289
11.1.3 MERATIVE 294
11.1.4 GOOGLE (ALPHABET, INC.) 298
11.1.5 INTEL CORPORATION 302
11.1.6 SIEMENS HEALTHINEERS 307
11.1.7 GE HEALTHCARE 311
11.1.8 ADVANCED MICRO DEVICES, INC 316
11.1.9 KONINKLIJKE PHILIPS N.V 319
11.1.10 DIGITAL DIAGNOSTICS, INC 323
11.1.11 INFORMAI 326
11.2 他の有力企業 328
11.2.1 HEARTFLOW, INC 328
11.2.2 ENLITIC, INC 328
11.2.3 AIDENCE 329
11.2.4 BUTTERFLY NETWORK, INC 329
11.2.5 NANO X IMAGING LTD 330
11.2.6 VIZ.AI, INC 330
11.2.7 QUIBIM 331
11.2.8 QURE.AI 331
11.2.9 THERAPIXEL 332
11.2.10 AIDOC 332
11.2.11 LUNIT, INC 333
11.2.12 ECHONOUS, INC 333
11.2.13 ICOMETRIX 334
11.2.14 BRAINOMIX 334
12 付録 335
12.1 ディスカッションガイド 335
12.2 ナレッジストア 338
12.3 カスタマイズオプション 340
12.4 関連レポート 340
12.5 執筆者の詳細 341
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 45
1.1 STUDY OBJECTIVES 45
1.2 MARKET DEFINITION 45
1.2.1 INCLUSIONS AND EXCLUSIONS 45
1.3 MARKET SCOPE 46
1.3.1 MARKETS COVERED 46
1.3.2 YEARS CONSIDERED 46
1.3.3 CURRENCY CONSIDERED 47
1.4 STAKEHOLDERS 47
1.5 SUMMARY OF CHANGES 47
1.6 RECESSION IMPACT 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.1.1 SECONDARY DATA 50
- 2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY DATA 51
- 2.1.2.1 Key data from primary sources 53
- 2.1.2.2 Key industry insights 53
2.2 MARKET SIZE ESTIMATION 54
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 59
2.4 ASSUMPTIONS 60
2.5 LIMITATIONS 60
2.5.1 SCOPE-RELATED LIMITATIONS 60
2.5.2 METHODOLOGY-RELATED LIMITATIONS 60
2.6 RISK ASSESSMENT 61
2.7 AI IN MEDICAL DIAGNOSTICS MARKET: RECESSION IMPACT ANALYSIS 61
3 EXECUTIVE SUMMARY 62
4 PREMIUM INSIGHTS 65
4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW 65
4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2022) 66
4.3 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
4.4 AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL MIX 67
4.5 AI IN MEDICAL DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.1.1 DRIVERS 69
- 5.1.1.1 Influx of big data 69
- 5.1.1.2 Growing cross-industry partnerships & collaborations 69
- 5.1.1.3 Increasing demand for AI-based solutions to reduce work pressure on radiologists 70
- 5.1.1.4 Rising government initiatives to support AI-based technologies 70
- 5.1.1.5 Availability of funding for AI-based startups 71
5.1.2 RESTRAINTS 72
- 5.1.2.1 Inadequate AI workforce and ambiguous regulatory guidelines for medical software 72
5.1.3 OPPORTUNITIES 72
- 5.1.3.1 Untapped emerging markets 72
- 5.1.3.2 Increasing focus on developing human-aware AI systems 73
5.1.4 CHALLENGES 73
- 5.1.4.1 Reluctance to adopt AI-based technologies 73
- 5.1.4.2 Budgetary constraints 74
- 5.1.4.3 Unstructured healthcare data 74
- 5.1.4.4 Data privacy concerns 74
- 5.1.4.5 Limited interoperability 75
5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 75
5.3 VALUE CHAIN ANALYSIS 75
5.3.1 UPSTREAM 76
5.3.2 MID-STREAM 77
5.3.3 DOWNSTREAM 77
5.4 ECOSYSTEM MAPPING 77
5.4.1 ROLE IN ECOSYSTEM 78
5.5 CASE STUDIES 79
5.5.1 MAYO CLINIC INTEGRATES AI-ENABLED DIGITAL DIAGNOSTICS AND BOOSTS MEDICAL RESEARCH WITH GOOGLE CLOUD PLATFORM 79
5.5.2 RESOLVING CHALLENGES OF UNDERSTAFFED WORKFORCE AND BACKLOG WITH VEYE LUNG NODULES 79
5.5.3 NVIDIA AI ENTERPRISE SOFTWARE AND GPUS HELP IMPROVE PERFORMANCE AND PRECISION OF TUMOR TARGETING 79
5.5.4 ZHEJIANG UNIVERSITY AND ZHEJIANG DE IMAGE SOLUTIONS USE INTEL AI SOLUTION TO PROCESS ULTRASOUND 80
5.5.5 WAITEMATA DISTRICT HEALTH BOARD PROJECT UTILIZES PRECISION-DRIVEN HEALTH SOLUTIONS 80
5.6 TECHNOLOGY ANALYSIS 81
5.6.1 MACHINE LEARNING 81
5.6.2 NATURAL LANGUAGE PROCESSING 81
5.6.3 COMPUTER VISION 81
5.7 PORTER’S FIVE FORCES ANALYSIS 82
5.7.1 THREAT OF NEW ENTRANTS 83
5.7.2 THREAT OF SUBSTITUTES 83
5.7.3 BARGAINING POWER OF SUPPLIERS 83
5.7.4 BARGAINING POWER OF BUYERS 83
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 84
5.8 INDUSTRY TRENDS 84
5.8.1 ARTIFICIAL INTELLIGENCE IN HEALTHCARE 84
- 5.8.1.1 Key to AI in Healthcare: Data 84
- 5.8.1.2 AR and MR in Healthcare Settings 84
- 5.8.1.3 Healthcare Privacy and Security in 2022 84
- 5.8.1.4 Growing demand for AI among companies offering at-home IVD testing services 85
5.9 TRADE ANALYSIS 85
5.10 TARIFF AND REGULATORY ANALYSIS 86
5.10.1 TARIFF FOR AI IN MEDICAL DIAGNOSTICS HARDWARE 86
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
5.10.3 NORTH AMERICA 90
- 5.10.3.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA) 91
- 5.10.3.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH) 91
- 5.10.3.3 Consumer Privacy Protection Act of 2017 91
- 5.10.3.4 National Cybersecurity Protection Advancement Act of 2015 91
- 5.10.3.5 Future of Life Institute’s Asilomar AI Principles 92
5.10.4 EUROPE 92
- 5.10.4.1 European Medical Devices Regulation (EU) 2017/745 and In-vitro Diagnostic Medical Devices Regulation (EU) 2017/746, in combination with General Data Protection Regulation 2016/679 92
- 5.10.4.2 AI Act (Artificial Intelligence Act) 92
5.10.5 ASIA PACIFIC 93
- 5.10.5.1 Cybersecurity Law of the People’s Republic of China 93
5.10.6 REST OF THE WORLD 93
- 5.10.6.1 Protection of Personal Information Act 93
5.11 PRICING ANALYSIS 94
5.11.1 AVERAGE SELLING PRICE TREND 95
5.12 PATENT ANALYSIS 95
5.12.1 PATENT PUBLICATION TRENDS FOR ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS 95
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
5.13 KEY CONFERENCES AND EVENTS (2023-2024) 98
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 99
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
5.14.2 BUYING CRITERIA 100
5.15 UNMET NEEDS: AI IN MEDICAL DIAGNOSTICS MARKET 101
5.16 END-USER EXPECTATIONS 102
5.17 REIMBURSEMENT SCENARIO 103
5.17.1 REIMBURSEMENT FOR AI SOFTWARE IN RADIOLOGY 105
6 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT 106
6.1 INTRODUCTION 107
6.2 SOFTWARE 107
6.2.1 USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS 107
6.3 SERVICES 109
6.3.1 RISING NEED TO DEPLOY AND INTEGRATE AI SYSTEMS TO SUPPORT MARKET GROWTH 109
6.4 HARDWARE 111
6.4.1 FREQUENT UPGRADES FOR OPTIMAL USE TO SUPPORT MARKET GROWTH 111
6.4.2 PROCESSORS 113
- 6.4.2.1 MPU 115
- 6.4.2.1.1 MPUs to hold largest share of processors market 115
- 6.4.2.2 GPU 116
- 6.4.2.2.1 GPUs play crucial role in enhancing accuracy and efficacy of imaging 116
- 6.4.2.3 FPGA 118
- 6.4.2.3.1 Wide usage potential to drive demand 118
- 6.4.2.4 ASIC 119
- 6.4.2.4.1 Rapid operations to support end-user demand 119
- 6.4.2.1 MPU 115
6.4.3 MEMORY 121
- 6.4.3.1 Development of high-bandwidth memory for AI applications to drive market 121
6.4.4 NETWORKS 122
- 6.4.4.1 Adapters 124
- 6.4.4.1.1 Adapters to hold largest share of networks market 124
- 6.4.4.2 Switches 126
- 6.4.4.3 Interconnects 127
- 6.4.4.3.1 Need for efficient data transmission to drive market 127
- 6.4.4.1 Adapters 124
7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION 129
7.1 INTRODUCTION 130
7.2 IN VIVO DIAGNOSTICS 131
7.2.1 IN VIVO DIAGNOSTICS MARKET, BY SPECIALTY 131
- 7.2.1.1 Radiology 133
- 7.2.1.1.1 AI-based diagnostic tools to reduce work pressure on radiologists 133
- 7.2.1.2 Cardiology 134
- 7.2.1.2.1 Rising complexities associated with CVD to drive market 134
- 7.2.1.3 Neurology 136
- 7.2.1.3.1 Increasing prevalence of critical brain disorders to drive market 136
- 7.2.1.4 Obstetrics/Gynecology 138
- 7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market 138
- 7.2.1.5 Ophthalmology 139
- 7.2.1.5.1 Rising need for early detection & prevention of eye diseases to drive market 139
- 7.2.1.6 Other specialties 141
- 7.2.1.1 Radiology 133
7.2.2 IN VIVO DIAGNOSTICS MARKET, BY MODALITY 142
- 7.2.2.1 CT 144
- 7.2.2.1.1 Rising availability of cardiac CT devices with AI solutions to drive market 144
- 7.2.2.2 X-ray 146
- 7.2.2.2.1 Innovative AI solutions for x-ray imaging by key players to drive market 146
- 7.2.2.3 MRI 147
- 7.2.2.3.1 Rising technological advancements to drive adoption of AI in MRI 147
- 7.2.2.4 Ultrasound 149
- 7.2.2.4.1 Increasing prevalence of ovarian cancer to boost demand 149
- 7.2.2.5 Other modalities 150
- 7.2.2.1 CT 144
7.3 IN VITRO DIAGNOSTICS 152
7.3.1 INCREASING ADOPTION OF POC TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH 152
8 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER 154
8.1 INTRODUCTION 155
8.2 HOSPITALS 156
8.2.1 INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET 156
8.3 DIAGNOSTIC IMAGING CENTERS 157
8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET 157
8.4 DIAGNOSTIC LABORATORIES 159
8.4.1 RISING SPECIMEN TEST VOLUMES TO DRIVE MARKET 159
8.5 OTHER END USERS 160
9 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY REGION 162
9.1 INTRODUCTION 163
9.2 NORTH AMERICA 164
9.2.1 NORTH AMERICA: RECESSION IMPACT 164
9.2.2 US 172
- 9.2.2.1 Increasing volume of imaging procedures to drive market 172
9.2.3 CANADA 178
- 9.2.3.1 Research grants and improved academics in radiology to drive market 178
9.3 EUROPE 184
9.3.1 EUROPE: RECESSION IMPACT 184
9.3.2 GERMANY 191
- 9.3.2.1 Rising government support to drive adoption of AI in medical diagnostics 191
9.3.3 FRANCE 197
- 9.3.3.1 Availability of funding for companies to enhance AI research in medical imaging 197
9.3.4 UK 203
- 9.3.4.1 Increasing radiography procedures to drive market 203
9.3.5 ITALY 209
- 9.3.5.1 Increasing volume of EHRs and EMRs due to rising geriatric population to drive demand for AI solutions 209
9.3.6 SPAIN 215
- 9.3.6.1 Growing awareness of AI in Spain to favor market growth 215
9.3.7 REST OF EUROPE 221
9.4 ASIA PACIFIC 227
9.4.1 ASIA PACIFIC: RECESSION IMPACT 227
9.4.2 CHINA 235
- 9.4.2.1 Rising use of AI in clinical decision-making to drive market 235
9.4.3 JAPAN 241
- 9.4.3.1 Strong healthcare infrastructure to drive uptake of advanced AI solutions 241
9.4.4 INDIA 246
- 9.4.4.1 Favorable government initiatives for R&D investments to drive market 246
9.4.5 REST OF ASIA PACIFIC 253
9.5 LATIN AMERICA 259
9.5.1 RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS 259
9.5.2 LATIN AMERICA: RECESSION IMPACT 259
9.6 MIDDLE EAST & AFRICA 265
9.6.1 GROWING HEALTHCARE EXPENDITURE FOSTER GROWTH OF AI 265
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 265
10 COMPETITIVE LANDSCAPE 271
10.1 OVERVIEW 271
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 271
10.3 REVENUE ANALYSIS 272
10.4 MARKET SHARE ANALYSIS 273
10.5 COMPANY EVALUATION MATRIX 275
10.5.1 STARS 275
10.5.2 EMERGING LEADERS 275
10.5.3 PERVASIVE PLAYERS 275
10.5.4 PARTICIPANTS 276
10.5.5 COMPANY FOOTPRINT ANALYSIS 276
10.6 START-UP/SME EVALUATION MATRIX 278
10.6.1 PROGRESSIVE COMPANIES 278
10.6.2 DYNAMIC COMPANIES 278
10.6.3 RESPONSIVE COMPANIES 278
10.6.4 STARTING BLOCKS 278
10.6.5 COMPETITIVE BENCHMARKING 279
10.7 COMPETITIVE SCENARIO 281
10.7.1 PRODUCT LAUNCHES & ENHANCEMENTS 281
10.7.2 DEALS 282
10.7.3 OTHER DEVELOPMENTS 283
11 COMPANY PROFILES 284
11.1 KEY PLAYERS 284
11.1.1 MICROSOFT 284
11.1.2 NVIDIA CORPORATION 289
11.1.3 MERATIVE 294
11.1.4 GOOGLE (ALPHABET, INC.) 298
11.1.5 INTEL CORPORATION 302
11.1.6 SIEMENS HEALTHINEERS 307
11.1.7 GE HEALTHCARE 311
11.1.8 ADVANCED MICRO DEVICES, INC 316
11.1.9 KONINKLIJKE PHILIPS N.V 319
11.1.10 DIGITAL DIAGNOSTICS, INC 323
11.1.11 INFORMAI 326
11.2 OTHER PLAYERS 328
11.2.1 HEARTFLOW, INC 328
11.2.2 ENLITIC, INC 328
11.2.3 AIDENCE 329
11.2.4 BUTTERFLY NETWORK, INC 329
11.2.5 NANO X IMAGING LTD 330
11.2.6 VIZ.AI, INC 330
11.2.7 QUIBIM 331
11.2.8 QURE.AI 331
11.2.9 THERAPIXEL 332
11.2.10 AIDOC 332
11.2.11 LUNIT, INC 333
11.2.12 ECHONOUS, INC 333
11.2.13 ICOMETRIX 334
11.2.14 BRAINOMIX 334
12 APPENDIX 335
12.1 DISCUSSION GUIDE 335
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 338
12.3 CUSTOMIZATION OPTIONS 340
12.4 RELATED REPORTS 340
12.5 AUTHOR DETAILS 341
TABLE 1 FACTOR ANALYSIS TABLE 2 RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET TABLE 3 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS TABLE 4 AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 5 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY US, 2022 TABLE 6 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY CHINA, 2022 TABLE 7 TARIFF FOR ELECTRONIC INTEGRATED CIRCUITS AS PROCESSORS AND CONTROLLERS EXPORTED BY GERMANY, 2020 TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 12 AVERAGE SELLING PRICE OF PROCESSORS, BY TYPE TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN AI IN MEDICAL DIAGNOSTICS MARKET TABLE 14 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR AI IN MEDICAL DIAGNOSTICS TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS TABLE 17 KEY BUYING CRITERIA FOR END USERS TABLE 18 AI IN MEDICAL DIAGNOSTICS MARKET: UNMET NEEDS TABLE 19 AI IN MEDICAL DIAGNOSTICS MARKET: END-USER EXPECTATIONS TABLE 20 SELECTED AI DEVICES THAT ARE REIMBURSED BY US MEDICARE TABLE 21 DIABETIC RETINOPATHY DIAGNOSIS CODING AND REIMBURSEMENT TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 24 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 25 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 26 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 27 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 28 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 29 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 30 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 31 AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 32 PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 33 PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 34 PROCESSORS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 35 PROCESSORS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 36 MPU MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 37 MPU MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 38 GPU MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 39 GPU MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 40 FPGA MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 41 FPGA MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 42 ASIC MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 43 ASIC MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 44 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 45 AI IN MEDICAL DIAGNOSTICS MEMORY MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 46 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 47 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 48 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 49 AI IN MEDICAL DIAGNOSTICS NETWORKS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 50 ADAPTERS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 51 ADAPTERS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 52 SWITCHES MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 53 SWITCHES MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 54 INTERCONNECTS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 55 INTERCONNECTS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 56 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 57 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 58 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 59 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 60 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 61 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC SPECIALTIES, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 62 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 63 AI IN MEDICAL DIAGNOSTICS FOR RADIOLOGY, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 64 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 65 AI IN MEDICAL DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 66 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 67 AI IN MEDICAL DIAGNOSTICS MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 68 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 69 AI IN MEDICAL DIAGNOSTICS MARKET FOR OBSTETRICS/GYNECOLOGY, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 70 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 71 AI IN MEDICAL DIAGNOSTICS MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 72 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 73 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 74 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 75 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 76 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 77 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTIC MODALITIES, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 78 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 79 AI IN MEDICAL DIAGNOSTICS MARKET FOR CT, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 80 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 81 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 82 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 83 AI IN MEDICAL DIAGNOSTICS MARKET FOR MRI, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 84 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 85 AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 86 FDA-APPROVED AI APPLICATIONS IN BREAST IMAGING TABLE 87 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 88 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 89 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 90 AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 91 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 92 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 93 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 94 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 95 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 96 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 97 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 98 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 99 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 100 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 101 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2017-2021 (USD MILLION) TABLE 102 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2022-2028 (USD MILLION) TABLE 103 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 104 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 105 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 106 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 107 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 108 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 109 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 110 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 111 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 112 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 113 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 114 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 115 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 116 NORTH AMERICA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 117 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 118 NORTH AMERICA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 119 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 120 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 121 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 122 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 123 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 124 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 125 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 126 US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 127 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 128 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 129 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 130 US: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 131 US: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 132 US: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 133 US: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 134 US: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 135 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 136 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 137 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 138 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 139 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 140 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 141 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 142 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 143 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 144 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 145 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 146 CANADA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 147 CANADA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 148 CANADA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 149 CANADA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 150 CANADA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 151 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 152 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 153 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 154 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 155 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 156 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 157 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 158 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 159 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 160 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 161 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 162 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 163 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 164 EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 165 EUROPE: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 166 EUROPE: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 167 EUROPE: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 168 EUROPE: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 169 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 170 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 171 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 172 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 173 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 174 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 175 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 176 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 177 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 178 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 179 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 180 GERMANY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 181 GERMANY: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 182 GERMANY: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 183 GERMANY: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 184 GERMANY: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 185 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 186 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 187 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 188 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 189 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 190 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 191 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 192 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 193 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 194 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 195 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 196 FRANCE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 197 FRANCE: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 198 FRANCE: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 199 FRANCE: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 200 FRANCE: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 201 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 202 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 203 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 204 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 205 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 206 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 207 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 208 UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 209 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 210 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 211 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 212 UK: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 213 UK: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 214 UK: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 215 UK: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 216 UK: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 217 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 218 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 219 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 220 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 221 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 222 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 223 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 224 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 225 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 226 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 227 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 228 ITALY: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 229 ITALY: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 230 ITALY: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 231 ITALY: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 232 ITALY: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 233 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 234 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 235 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 236 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 237 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 238 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 239 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 240 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 241 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 242 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 243 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 244 SPAIN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 245 SPAIN: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 246 SPAIN: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 247 SPAIN: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 248 SPAIN: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 249 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 250 SPAIN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 251 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 252 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 253 REST OF EUROPE: AI IN MEDICA DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 254 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 255 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 256 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 257 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 258 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 259 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 260 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 261 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 262 REST OF EUROPE: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 263 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 264 REST OF EUROPE: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 265 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 266 REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 267 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2021 (USD MILLION) TABLE 268 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2022-2028 (USD MILLION) TABLE 269 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 270 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 271 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 272 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 273 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 274 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 275 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 276 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 277 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 278 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 279 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 280 ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 281 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 282 ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 283 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 284 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 285 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 286 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 287 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 288 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 289 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 290 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 291 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 292 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 293 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 294 CHINA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 295 CHINA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 296 CHINA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 297 CHINA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 298 CHINA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 299 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 300 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 301 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 302 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 303 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 304 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 305 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 306 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 307 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 308 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 309 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 310 JAPAN: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 311 JAPAN: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 312 JAPAN: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 313 JAPAN: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 314 JAPAN: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 315 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 316 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 317 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 318 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 319 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 320 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 321 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 322 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 323 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 324 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 325 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 326 INDIA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 327 INDIA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 328 INDIA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 329 INDIA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 330 INDIA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 331 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 332 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 333 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 334 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 335 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 336 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 337 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 338 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 339 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 340 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 341 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 342 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 343 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 344 REST OF ASIA PACIFIC: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 345 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 346 REST OF ASIA PACIFIC: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 347 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 348 REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 349 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 350 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 351 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 352 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 353 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 354 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 355 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 356 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 357 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021(USD MILLION) TABLE 358 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 359 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 360 LATIN AMERICA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 361 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 362 LATIN AMERICA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 363 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 364 LATIN AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 365 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2021 (USD MILLION) TABLE 366 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022-2028 (USD MILLION) TABLE 367 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2017-2021 (USD MILLION) TABLE 368 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2022-2028 (USD MILLION) TABLE 369 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2017-2021 (USD MILLION) TABLE 370 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2022-2028 (USD MILLION) TABLE 371 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2017-2021 (USD MILLION) TABLE 372 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022-2028 (USD MILLION) TABLE 373 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 374 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS HARDWARE MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 375 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 376 MIDDLE EAST & AFRICA: PROCESSORS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 377 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2017-2021 (USD MILLION) TABLE 378 MIDDLE EAST & AFRICA: NETWORKS MARKET, BY TYPE, 2022-2028 (USD MILLION) TABLE 379 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2017-2021 (USD MILLION) TABLE 380 MIDDLE EAST & AFRICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022-2028 (USD MILLION) TABLE 381 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS TABLE 382 AI IN MEDICAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION TABLE 383 OVERALL COMPANY FOOTPRINT (TEN PLAYERS) TABLE 384 APPLICATION (IN VIVO DIAGNOSTIC MODALITIES) FOOTPRINT (TEN PLAYERS) TABLE 385 REGIONAL FOOTPRINT (TEN PLAYERS) TABLE 386 AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES TABLE 387 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) TABLE 388 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2020-SEPTEMBER 2023 TABLE 389 KEY DEALS, JANUARY 2020-SEPTEMBER 2023 TABLE 390 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS (JANUARY 2020-SEPTEMBER 2023) TABLE 391 MICROSOFT: COMPANY OVERVIEW TABLE 392 NVIDIA CORPORATION: COMPANY OVERVIEW TABLE 393 MERATIVE: COMPANY OVERVIEW TABLE 394 GOOGLE: COMPANY OVERVIEW TABLE 395 INTEL CORPORATION: COMPANY OVERVIEW TABLE 396 SIEMENS HEALTHINEERS: COMPANY OVERVIEW TABLE 397 GE HEALTHCARE: COMPANY OVERVIEW TABLE 398 ADVANCED MICRO DEVICES, INC.: COMPANY OVERVIEW TABLE 399 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW TABLE 400 DIGITAL DIAGNOSTICS, INC.: COMPANY OVERVIEW TABLE 401 INFORMAI: COMPANY OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 PRIMARY SOURCES FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING FIGURE 5 MARKET SIZE ESTIMATION FIGURE 6 AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028) FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS FIGURE 8 TOP-DOWN APPROACH FIGURE 9 DATA TRIANGULATION METHODOLOGY FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) FIGURE 12 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) FIGURE 13 GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET FIGURE 14 RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF BIG DATA TO DRIVE MARKET FIGURE 15 IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA IN 2022 FIGURE 16 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 20 REVENUE SHIFT & NEW REVENUE POCKETS FOR AI IN MEDICAL DIAGNOSTICS FIGURE 21 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN FIGURE 22 AI IN MEDICAL DIAGNOSTICS MARKET: ECOSYSTEM FIGURE 23 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND) FIGURE 24 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN AI IN MEDICAL DIAGNOSTICS MARKET 2022 (USD THOUSAND) FIGURE 25 ALGORITHMS CLEARED BY US FDA, 2008 TO 2023 FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY HARDWARE (PROCESSOR) FIGURE 27 PATENT PUBLICATION TRENDS (2019-2023) FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR AI IN MEDICAL DIAGNOSTICS (2019-2023) FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS FIGURE 30 KEY BUYING CRITERIA FOR END USERS FIGURE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT FIGURE 32 ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2017-2022 FIGURE 34 AI IN MEDICAL DIAGNOSTICS: MARKET SHARE ANALYSIS (2022) FIGURE 35 AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2022) FIGURE 36 AI IN MEDICAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022 FIGURE 37 AI IN MEDICAL DIAGNOSTICS MARKET: START0UP/SME EVALUATION MATRIX (2022) FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022) FIGURE 39 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 40 IBM: COMPANY SNAPSHOT (2021) FIGURE 41 GOOGLE: COMPANY SNAPSHOT (2022) FIGURE 42 INTEL CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 43 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022) FIGURE 45 XILINX & ADVANCED MICRO DEVICES, INC.: COMPANY SNAPSHOT (2022) FIGURE 46 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
